Comparison between Rubicon Research IPO and Trualt Bioenergy IPO.
Rubicon Research IPO is a Mainboard Bookbuilding IPO proposed to list at BSE, NSE while Trualt Bioenergy IPO is a Mainboard Bookbuilding proposed to list at BSE, NSE.
The total issue size of Rubicon Research IPO is up to ₹1,377.68 Cr whereas the issue size of the Trualt Bioenergy IPO is up to ₹839.28 Cr. The final issue price of Rubicon Research IPO is ₹485.00 per share and of Trualt Bioenergy IPO is ₹496.00 per share.
| Rubicon Research IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Face Value | ₹1 per share | ₹10 per share |
| Issue Price (Lower) | ₹461.00 per share | ₹472.00 per share |
| Issue Price (Upper) | ₹485.00 per share | ₹496.00 per share |
| Issue Price (Final) | ₹485.00 per share | ₹496.00 per share |
| Discount (Retail) | ||
| Discount (Employee) | ₹46.00 per share | |
| Market Lot Size | 30 shares | 30 shares |
| Fresh Issue Size | 1,03,13,058 shares | 1,51,20,967 shares |
| Fresh Issue Size (Amount) | up to ₹500.18 Cr | up to ₹750.00 Cr |
| OFS Issue Size | 1,80,92,783 shares | 18,00,000 shares |
| OFS Issue Size (Amount) | up to ₹877.50 Cr | up to ₹89.28 Cr |
| Issue Size Total | 2,84,05,841 shares | 1,69,20,967 shares |
| Issue Size Total (Amount) | up to ₹1,377.68 Cr | up to ₹839.28 Cr |
Rubicon Research IPO opens on Oct 09, 2025, while Trualt Bioenergy IPO opens on Sep 25, 2025. The closing date of Rubicon Research IPO and Trualt Bioenergy IPO is Oct 13, 2025, and Sep 29, 2025, respectively.
| Rubicon Research IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Anchor Bid Date | Oct 08, 2025 | Sep 24, 2025 |
| Issue Open | Oct 09, 2025 | Sep 25, 2025 |
| Issue Close | Oct 13, 2025 | Sep 29, 2025 |
| Basis Of Allotment (Tentative) | Oct 14, 2025 | Sep 30, 2025 |
| Initiation of Refunds (Tentative) | Oct 15, 2025 | Oct 01, 2025 |
| Credit of Share (Tentative) | Oct 15, 2025 | Oct 01, 2025 |
| Listing date (Tentative) | Oct 16, 2025 | Oct 03, 2025 |
| Anchor Lockin End date 1 | Nov 12, 2025 | Oct 29, 2025 |
| Anchor Lockin End date 2 | Jan 11, 2026 | Dec 28, 2025 |
Rubicon Research IPO P/E ratio is 55.75, as compared to Trualt Bioenergy IPO P/E ratio of 23.89.
| Rubicon Research IPO | Trualt Bioenergy IPO | ||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Financials | Company Financials (Restated Consolidated)Rubicon Research Ltd.'s revenue increased by 49% and profit after tax (PAT) rose by 48% between the financial year ending with March 31, 2025 and March 31, 2024.
| Company Financials (Restated Consolidated)Trualt Bioenergy Ltd.'s revenue increased by 54% and profit after tax (PAT) rose by 361% between the financial year ending with March 31, 2025 and March 31, 2024.
| |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Pre-Issue) | 75.71 | 88.2 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Promoter Shareholding (Post-Issue) | 59.78 | 70.55 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| P/E Ratio | 55.75 | 23.89 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Market Cap | ₹7990.21 Cr. | ₹4253.33 Cr. | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROE | 29.02% | 28.27% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| ROCE | 26.45% | 10.88% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| Debt/Equity | 0.73 | 2.02 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| EPS | ₹8.70 | ₹20.76 | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
| RoNW | 29.02% | 19.07% | |||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||||
In the Rubicon Research IPO Retail Individual Investors (RII) are offered 28,36,597 shares while in Trualt Bioenergy IPO retail investors are offered 28,36,597 shares. Qualified Institutional Buyers (QIB) are offered 85,09,794 shares in Rubicon Research IPO and 33,84,193 shares in Trualt Bioenergy IPO.
| Rubicon Research IPO | Trualt Bioenergy IPO | |
|---|---|---|
| Anchor Investor Reservation | 1,27,64,691 shares | 50,76,289 shares |
| Market Maker Reservation | 0 shares | 0 shares |
| QIB | 85,09,794 shares | 33,84,193 shares |
| NII | 42,54,896 shares | 25,38,146 shares |
| RII | 28,36,597 shares | 59,22,339 shares |
| Employee | 39,863 shares | 0 shares |
| Others | ||
| Total | 2,84,05,841 shares | 1,69,20,967 shares |
Rubicon Research IPO subscribed 109.35x in total, whereas Trualt Bioenergy IPO subscribed 75.02x.
| Rubicon Research IPO | Trualt Bioenergy IPO | |
|---|---|---|
| QIB (times) | 137.09x | 165.16x |
| NII (times) | 102.70x | 103.04x |
| Big NII (times) | 117.77x | 118.62x |
| Small NII (times) | 72.57x | 71.87x |
| RII (times) | 37.40x | 11.50x |
| Employee (times) | 17.68x | |
| Other (times) | ||
| Total (times) | 109.35x | 75.02x |
